The anti-angiogenic agent lenvatinib induces tumor vessel normalization and enhances radiosensitivity in hepatocellular tumors
Norikazu Une, Mayumi Takano-Kasuya, Narufumi Kitamura, Mineto Ohta, Tomoya Inose, C. Kato, Ryuichi Nishimura, Hiroshi Tada, Shigehito Miyagi, Takanori Ishida, Michiaki Unno, Takashi Kamei, Kohsuke Gonda
Topics & Concepts
LenvatinibSorafenibMedicineHepatocellular carcinomaAngiogenesisCancer researchTyrosine-kinase inhibitorInternal medicinePharmacologyOncologyPathologyCancerHepatocellular Carcinoma Treatment and PrognosisAngiogenesis and VEGF in CancerCancer, Hypoxia, and Metabolism